These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6430366)

  • 21. Long-term results of the treatment of children with factor VIII inhibitors with prothrombin-complex concentrates.
    Ekert H; Smibert E; Exton J
    Med J Aust; 1987 Sep; 147(5):230-3. PubMed ID: 3118153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of haemorrhages in a haemophiliac with factor-VIII inhibitor (author's transl)].
    Angelkort B; Stürner KH
    Dtsch Med Wochenschr; 1979 Feb; 104(5):182-6. PubMed ID: 759178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience.
    Tjønnfjord GE
    Haemophilia; 2004 Sep; 10 Suppl 2():41-5. PubMed ID: 15385045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A child with acquired haemophilia.
    Somaratne PD; Jansan J; Senanayake HM; Ratnamalala V; Jayathilake MM; Thirumavalavan K
    Ceylon Med J; 2014 Jun; 59(2):66-7. PubMed ID: 24977427
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnosis and treatment of acquired haemophilia.
    Baudo F; Caimi T; de Cataldo F
    Haemophilia; 2010 May; 16(102):102-6. PubMed ID: 20536992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors in congenital coagulation disorders.
    Key NS
    Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acquired haemophilia (acquired factor VIII inhibitor)].
    Ceresetto JM; Duboscq C; Fondevila C; Tezanos Pinto M
    Medicina (B Aires); 2015; 75(4):231-8. PubMed ID: 26339881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex dental extractions in a patient with severe haemophilia A and inhibitors treated with activated prothrombin complex concentrate.
    Zanon E; Brandolin B; Saggiorato G; Bacci C
    Blood Transfus; 2012 Apr; 10(2):225-7. PubMed ID: 22337269
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemophiliacs with inhibitors: therapeutic options.
    Roberts HR
    N Engl J Med; 1981 Sep; 305(13):757-8. PubMed ID: 6790992
    [No Abstract]   [Full Text] [Related]  

  • 30. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period.
    Yee TT; Taher A; Pasi KJ; Lee CA
    Clin Lab Haematol; 2000 Oct; 22(5):275-8. PubMed ID: 11122268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated ppsb in the treatment of a patient with haemophilia and antibodies to factor VIII.
    Ekert H; McVeagh P
    Med J Aust; 1975 Oct; 2(17):675-7. PubMed ID: 1207551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of factor VIII inhibitors.
    Acharya SS; DiMichele DM
    Best Pract Res Clin Haematol; 2006; 19(1):51-66. PubMed ID: 16377541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parallel use of by-passing agents in haemophilia with inhibitors: a critical review.
    Ingerslev J; Sørensen B
    Br J Haematol; 2011 Oct; 155(2):256-62. PubMed ID: 21895627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surreptitious bleeding in surgery: a major challenge in coagulation.
    Rice L
    Clin Lab Haematol; 2000 Oct; 22 Suppl 1():17-20; discussion 30-2. PubMed ID: 11251654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
    Economou M; Teli A; Tzantzaroudi A; Tsatra I; Zavitsanakis A; Athanassiou-Metaxa M
    Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitors in haemophilia: clinical aspects.
    Dimichele D; Rivard G; Hay C; Antunes S
    Haemophilia; 2004 Oct; 10 Suppl 4():140-5. PubMed ID: 15479387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
    Zwahlen H; Beck EA
    Acta Haematol; 1980; 64(1):12-7. PubMed ID: 6774572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.
    Björkman S; Berntorp E
    Clin Pharmacokinet; 2001; 40(11):815-32. PubMed ID: 11735604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.